Press release
Global Epilepsy Monitoring Devices Market Set for Robust Growth, Projected to Reach USD 894.63 Million by 2033 Driven by Innovations in Wearable Technology | FMI
The global epilepsy monitoring devices market is on a strong growth trajectory, with projections estimating a market value of USD 523.26 million in 2023. According to recent industry reports, this market is set to grow significantly over the next decade, reaching USD 894.63 million by 2033. This represents a substantial compound annual growth rate (CAGR) of 5.5% during the forecast period.Epilepsy, a common neurological disorder affecting millions worldwide, necessitates continuous monitoring to understand and manage seizure activity effectively. The rising elderly population, who are more susceptible to epilepsy, is a major factor influencing market dynamics. In response, the development of wearable epilepsy monitoring devices has gained traction, providing patients with convenient, portable solutions that deliver real-time data on seizures.
๐๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง๐ญ๐จ ๐๐๐ซ๐ค๐๐ญ ๐๐จ๐ฏ๐๐ฆ๐๐ง๐ญ๐ฌ: ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ! https://www.futuremarketinsights.com/report-sample#5245502d47422d3134333134
The wearable segment is experiencing remarkable growth, with a 15.1% increase in recent years. While advancements in wearable and AI-powered systems are reshaping the market, traditional devices such as EEG (electroencephalogram) and VEEG (video EEG) systems continue to form the backbone of epilepsy monitoring, especially in clinical settings.
Hospitals hold a substantial 45% share of the epilepsy monitoring equipment market. This is due to the advanced facilities and expertise required for diagnosing and monitoring epilepsy, often necessitating long-term observation in specialized units like Epilepsy Monitoring Units (EMU).
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ซ๐ค๐๐ญ
Regionally, North America dominates the epilepsy monitoring devices market with a 39% share, attributed to the presence of leading manufacturers, favorable government initiatives, and the adoption of advanced technologies such as AI-powered devices. Meanwhile, Europe also represents a significant market, with a 29% share in 2020, bolstered by robust healthcare infrastructure and the increasing acceptance of telemedicine for epilepsy care.
The Asia Pacific region is emerging as a key player, boasting an impressive growth rate of 8.15%. This growth can be linked to rising prevalence rates of epilepsy, increased healthcare expenditures, and growing public awareness of the condition. Furthermore, the cost-effectiveness of monitoring devices is a crucial factor fueling the market's expansion in this region.
As the landscape of epilepsy care evolves, innovations in monitoring technology promise to enhance patient outcomes and accessibility. Stakeholders in the healthcare sector are encouraged to invest in research and development to meet the changing needs of patients and healthcare professionals alike.
๐๐๐ข๐ ๐ก๐ญ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ญ๐๐ซ๐๐ฌ๐ญ: ๐๐ฎ๐ซ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ฑ๐ญ๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ! https://www.futuremarketinsights.com/reports/epilepsy-monitoring-devices-market
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
New players can enter the competitive environment of epilepsy monitoring equipment. Even though the market is dominated by sizable firms, fresh strategies, and advances are possible. Companies that cater to the market compete fiercely, allowing the market to be dynamic.
Companies' new tactics center around accuracy and precision. Brands are using new technologies to develop new products such as seizure sleep monitors and smartwatch seizure detection gadgets.
๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ
โข Nihon Kohden has developed EEG electrodes that may aid in the prevention of cross-contamination among patients and healthcare personnel.
โข Natus Medical has collaborated with Holberg to create and deploy an auto-scoring system that aids in the classification of electroencephalography (EEG).
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
โข Nihon Kohden Corporation
โข Medtronic PLC
โข General Electric Company
โข Koninklijke Philips N.V.
โข Compumedics Limited
โข Natus Medical Incorporated
โข EB Neuro S.p.A.
โข Cadwell Industries, Inc.
โข BrainScope Company, Inc.
โข LivaNova PLC
๐๐ฉ๐ญ๐ข๐ฆ๐ข๐ณ๐ ๐๐จ๐ฎ๐ซ ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ฒ ๐ฐ๐ข๐ญ๐ก ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ! https://www.futuremarketinsights.com/industry-analysis/diagnostic-devices
๐๐๐ฒ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ
๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ:
โข Wearable Devices
โข Conventional Devices
๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ:
โข Hospitals
โข Ambulatory Surgery Centers and clinic
โข Neurology Centers
โข Diagnostic centers
โข Home Care Settings
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง:
โข North America
โข Latin America
โข Western Europe
โข Eastern Europe
โข Asia Pacific Excluding Japan (APEJ)
โข Japan
โข The Middle East & Africa (MEA)
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ ๐๐'๐ฌ ๐๐๐ฅ๐๐ญ๐๐ ๐๐ง๐ ๐จ๐ข๐ง๐ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐จ๐ฆ๐๐ข๐ง:
๐๐จ๐ซ๐ญ๐๐๐ฅ๐ ๐๐๐๐ข๐๐๐ฅ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ - ๐๐ซ๐จ๐ฐ๐ญ๐ก & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐-๐๐๐๐: https://www.futuremarketinsights.com/reports/portable-medical-devices-market
๐๐ข๐ญ๐๐ฅ ๐๐ข๐ ๐ง๐ฌ ๐๐จ๐ง๐ข๐ญ๐จ๐ซ๐ข๐ง๐ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ - ๐๐ซ๐๐ง๐๐ฌ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐-๐๐๐๐: https://www.futuremarketinsights.com/reports/vital-signs-monitoring-devices-market
๐๐ซ๐๐ง๐ฌ๐๐ฎ๐ญ๐๐ง๐๐จ๐ฎ๐ฌ ๐๐จ๐ง๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ - ๐๐ซ๐จ๐ฐ๐ญ๐ก, ๐๐๐ฆ๐๐ง๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐-๐๐๐๐: https://www.futuremarketinsights.com/reports/transcutaneous-monitors-market
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Epilepsy Monitoring Devices Market Set for Robust Growth, Projected to Reach USD 894.63 Million by 2033 Driven by Innovations in Wearable Technology | FMI here
News-ID: 3872614 • Views: โฆ
More Releases from Future Market Insights Inc

Endoscopy Fluid Management Systems Market Poised for Significant Growth, Project โฆ
The global Endoscopy Fluid Management Systems Market is on a trajectory of significant expansion, with a new market forecast projecting its value to more than double over the next decade. According to the latest analysis, the market, valued at an estimated USD 550.3 million in 2025, is expected to surge to USD 1,123.7 million by 2035. This robust growth represents a compound annual growth rate (CAGR) of 7.4% and isโฆ

NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 โฆ
A new market analysis projects the global Next-Generation Sequencing (NGS) Sample Preparation market to experience a significant surge, forecasting a valuation of USD 7.0 billion by 2035. This marks a substantial increase from its estimated USD 1.9 billion value in 2025, reflecting a robust Compound Annual Growth Rate (CAGR) of 13.7% over the decade. The findings underscore the pivotal role of sample preparation in the expanding field of genomics, drivenโฆ

Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Indus โฆ
The global Eye and Face Protection Market is poised for significant expansion, with a new forecast predicting it will grow from an estimated USD 859.3 million in 2025 to USD 2,332.2 million by 2035. This robust growth trajectory represents a compound annual growth rate (CAGR) of 10.5% over the forecast period, driven by a confluence of rising industrial safety awareness, stringent regulatory mandates, and technological innovation.
Click Here for More Information:-โฆ

Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, I โฆ
The global market for dermatology excimer lasers is projected to surge from an estimated USD 109.7 million in 2025 to a remarkable USD 317.1 million by 2035, marking a significant compound annual growth rate (CAGR) of 11.2%. This substantial expansion is being fueled by a combination of factors, including the rising global prevalence of chronic skin conditions and a growing preference for advanced, targeted therapies.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/dermatology-excimer-lasers-market
Dermatologyโฆ
More Releases for Epilepsy
Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Globalโฆ
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Epilepsy Market are:
โข Idexx Laboratories Inc.
โข PBD Biotech Ltd
โข Thermo Fisher Scientific Inc.
โข Innovative Diagnostics SAS
โข Neogen Corp
โข Enfer Labs
โข bioMerieux SA
โข Ring Biotechnology Co Ltd
โข Bionote Inc.
โข Shenzhen Bioeasy Biotechnology Co Ltd.
Contact Us:
If you have any queries about this report or ifโฆ
Epilepsy Market: Trends, Opportunities, and Challenges
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. This condition affects millions of people globally, making it one of the most common neurological disorders. As the global burden of epilepsy increases, the demand for effective treatments and solutions continues to grow. The epilepsy market is evolving rapidly, with advancements in medication, diagnostics, and therapeutic technologies. This guest post aimsโฆ
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 โฆ
The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐
๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ: https://www.alliedmarketresearch.com/request-sample/A14821
Epilepsy devices playโฆ
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei โฆ
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029
Thisโฆ
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy โฆ
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curveโฆ